Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0FN6F
|
|||
Drug Name |
PMID26924192-Compound-25
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
KAINOS MEDICINE, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H21ClN4O4S
|
|||
Canonical SMILES |
CCS(=O)(=O)OCC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C
|
|||
InChI |
1S/C21H21ClN4O4S/c1-4-31(27,28)30-12-18-21-25-24-13(2)26(21)19-10-9-16(29-3)11-17(19)20(23-18)14-5-7-15(22)8-6-14/h5-11,18H,4,12H2,1-3H3/t18-/m0/s1
|
|||
InChIKey |
YVHHEUZAFNGTKI-SFHVURJKSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [1] |
Target's Patent Info | Bromodomain-containing protein 4 (BRD4) | Target's Patent Info | [1] | |
WikiPathways | Chemical Compounds to monitor Proteins |
References | Top | |||
---|---|---|---|---|
REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.